Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Hee Je Kim; Hyun Jung Sohn; Jung A. Hong; Hyun Joo Lee; Dae Hee Sohn; Chang Ae Shin; Hyun Il Cho; Woo Sung Min; Tai Gyu Kim

doi:10.1038/s41409-018-0383-2

Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Hee Je Kim
, Hyun Jung Sohn
, Jung A. Hong
, Hyun Joo Lee
, Dae Hee Sohn
, Chang Ae Shin
, Hyun Il Cho
, Woo Sung Min
, Tai Gyu Kim

Department of Internal Medicine

The Catholic University of Korea

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Pages (from-to)	903-906
Number of pages	4
Journal	Bone Marrow Transplantation
Volume	54
Issue number	6
DOIs	https://doi.org/10.1038/s41409-018-0383-2
State	Published - 1 Jun 2019

Access to Document

10.1038/s41409-018-0383-2

Cite this

@article{2da2ad69997d4ff285b149d6cc2f1785,

title = "Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial",

author = "Kim, \{Hee Je\} and Sohn, \{Hyun Jung\} and Hong, \{Jung A.\} and Lee, \{Hyun Joo\} and Sohn, \{Dae Hee\} and Shin, \{Chang Ae\} and Cho, \{Hyun Il\} and Min, \{Woo Sung\} and Kim, \{Tai Gyu\}",

year = "2019",

month = jun,

day = "1",

doi = "10.1038/s41409-018-0383-2",

language = "English",

volume = "54",

pages = "903--906",

journal = "Bone Marrow Transplantation",

issn = "0268-3369",

publisher = "Springer Nature",

number = "6",

}

TY - JOUR

T1 - Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia

T2 - a prospective clinical phase I/II trial

AU - Kim, Hee Je

AU - Sohn, Hyun Jung

AU - Hong, Jung A.

AU - Lee, Hyun Joo

AU - Sohn, Dae Hee

AU - Shin, Chang Ae

AU - Cho, Hyun Il

AU - Min, Woo Sung

AU - Kim, Tai Gyu

PY - 2019/6/1

Y1 - 2019/6/1

UR - https://www.scopus.com/pages/publications/85056309641

U2 - 10.1038/s41409-018-0383-2

DO - 10.1038/s41409-018-0383-2

M3 - Letter

C2 - 30410082

AN - SCOPUS:85056309641

SN - 0268-3369

VL - 54

SP - 903

EP - 906

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

IS - 6

ER -

Post-transplant immunotherapy with WT1-specific CTLs for high-risk acute myelogenous leukemia: a prospective clinical phase I/II trial

Access to Document

Other files and links

Cite this